Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.
Diabetic Neuropathies
Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines.
Cdc20, an activator at last.
See All 26 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cdc20, an activator at last.
Benanti JA, Toczyski DP. Cdc20, an activator at last. Mol Cell. 2008 Nov 21; 32(4):460-1.
View in:
PubMed
subject areas
Anaphase-Promoting Complex-Cyclosome
Animals
Cadherins
Cdc20 Proteins
Cell Cycle Proteins
Protein Binding
Protein Structure, Tertiary
Substrate Specificity
Ubiquitination
Ubiquitin-Protein Ligase Complexes
Xenopus
Xenopus Proteins
authors with profiles
Jennifer A Benanti PhD